Xalatan® [clinicaltrials_resource:NCT00716742/group/O3]
latanoprost 0.005%
group [clinicaltrials_vocabulary:group]
NCT00716742 measurement [clinicaltrials_resource:NCT00716742/measurement/0b60756c6a31ed9bee655e9c96354291]NCT00716742 measurement [clinicaltrials_resource:NCT00716742/measurement/54ad6068f42d24c36896ea676ae9b524]NCT00716742 measurement [clinicaltrials_resource:NCT00716742/measurement/e675b84f72c43841061156e25df6c98e]
group id [clinicaltrials_vocabulary:group-id]
Xalatan® [clinicaltrials_resource:NCT00716742/group/O3]
latanoprost 0.005%
Bio2RDF identifier
NCT00716742/group/O3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00716742/group/O3
group id [clinicaltrials_vocabulary:group-id]
description
latanoprost 0.005%
@en
identifier
clinicaltrials_resource:NCT00716742/group/O3
title
Xalatan®
@en
type
label
Xalatan® [clinicaltrials_resource:NCT00716742/group/O3]
@en